|
Alfaro R, Llorente S, Gonzalez-Martinez G, Jimenez-Coll V, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, de la Pena-Moral J, Minguela A, Legaz I, Muro M. Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients. Transplant Proc. 2023 Jan-Feb;55(1):66-71. doi: 10.1016/j.transproceed.2022.12.012. Epub 2023 Jan 6. PubMed PMID: 36621349.
AÑO: 2023; IF: 0.8
|
36621349
|
Martinez-Banaclocha H, Garcia-Palenciano C, Martinez-Alarcon L, Amores-Iniesta J, Martin-Sanchez F, Ercole GA, Gonzalez-Lisorge A, Fernandez-Pacheco J, Martinez-Gil P, Padilla-Rodriguez J, Baroja-Mazo A, Pelegrin P, Martinez-Garcia JJ. Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients. Front Immunol. 2023 Nov 29;14:1297249. doi: 10.3389/fimmu.2023.1297249. eCollection 2023. PubMed PMID: 38094297; PubMed Central PMCID: PMC10716420.
AÑO: 2023; IF: 5.7
|
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Banaclocha HM, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia. Clin Transl Oncol. 2023 May;25(5):1446-1454. doi: 10.1007/s12094-022-03042-z. Epub 2023 Jan 4. PubMed PMID: 36598635.
AÑO: 2023; IF: 2.8
|
|
Jimenez-Coll V, Llorente S, Boix F, Alfaro R, Galian JA, Martinez-Banaclocha H, Botella C, Moya-Quiles MR, Muro-Perez M, Minguela A, Legaz I, Muro M. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome. Int J Mol Sci. 2023 Feb 15;24(4):3908. doi: 10.3390/ijms24043908. PubMed PMID: 36835314; PubMed Central PMCID: PMC9963702.
AÑO: 2023; IF: 4.9
|
|
Jimenez-Coll V, El Kaaoui El Band J, Llorente S, Gonzalez-Lopez R, Fernandez-Gonzalez M, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, Minguela A, Legaz I, Muro M. All That Glitters in cfDNA Analysis Is Not Gold or Its Utility Is Completely Established Due to Graft Damage: A Critical Review in the Field of Transplantation. Diagnostics (Basel). 2023 Jun 6;13(12):1982. doi: 10.3390/diagnostics13121982. PubMed PMID: 37370877; PubMed Central PMCID: PMC10297394.
AÑO: 2023; IF: 3.0
|